Related Experiment Videos
General keynote: molecular therapeutics and pharmocogenomics
Robert C Bast1, Gordon B Mills
1University of Texas M. D. Anderson Cancer Center.
Gynecologic Oncology
|February 15, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers.
Science translational medicine·2017
Development and Validation of an Ultradeep Next-Generation Sequencing Assay for Testing of Plasma Cell-Free DNA from Patients with Advanced Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2017
Molecular heterogeneity at the network level: high-dimensional testing, clustering and a TCGA case study.
Bioinformatics (Oxford, England)·2017
Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human Cancer.
Cancer research·2017
Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study.
Gynecologic oncology·2026
Long-term storage stability of uracil in plasma.
Scandinavian journal of clinical and laboratory investigation·2026
Polygonatum cyrtonema Polysaccharides Alleviate Sleep Deprivation-Induced Behavioral Disorders via Gut Microbiota-Dependent Regulation of the Butyrate-HDAC3 Signaling Axis.
Journal of agricultural and food chemistry·2026